Business
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
BOSTON and SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that management plans to participate in two upcoming investor conferences. Jefferies Global Healthcare Conference (New York City) – fireside chat on Wednesday, June 3, 2026, at 8:4
About this update from Rapport Therapeutics, Inc.
[{"type":"image","alt":"Rapport Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Rapport Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":153,"url":"https://media.zenfs.com/en/globenewswire.com/398dec8a80e8c3a1c183590a167a19e7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bJEA9v0oN3uart2zzjf72Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxNA--/https://media.zenfs.com/en/globenewswire.com/398dec8a80e8c3a1c183590a167a19e7","width":300,"height":153},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/bJEA9v0oN3uart2zzjf72Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxNA--/https://media.zenfs.com/en/globenewswire.com/398dec8a80e8c3a1c183590a167a19e7","width":300,"height":153}},"lazy":false},{"type":"text","content":"BOSTON and SAN DIEGO, May 20, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that management plans to participate in two upcoming investor conferences.","length":394,"tagName":"p"},{"type":"text","content":"Jefferies Global Healthcare Conference (New York City) – fireside chat on Wednesday, June 3, 2026, at 8:45 am ET.","length":113,"tagName":"p"},{"type":"text","content":"Goldman Sachs 47th Annual Global Healthcare Conference (Miami, FL) – fireside chat on Monday, June 8, 2026, at 1:20 pm ET.","length":122,"tagName":"p"},{"type":"text","content":"Interested parties may access the live and archived webcasts of these fireside chats under the “Investors” section of the company’s website at: https://investors.rapportrx.com.","length":176,"tagName":"p"},{"type":"text","content":"About Rapport TherapeuticsRapport Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing small molecule precision medicines for patients with neurological and psychiatric disorders. The Company’s founders made pioneering discoveries related to the function of receptor associated proteins (RAPs) in the brain, which form the basis of Rapport’s RAP technology platform. The platform enables a differentiated approach to generate precision small molecule product candidates with the potential to overcome many limitations of conventional neur...